Faculty

Parveen Bhatti

Affiliate Associate Professor, Epidemiology


bhattip@gmail.com

Education

PhD Environmental Health, University of Washington, 2006
MSc Occupational and Environmental Hygiene, University of British Columbia (Canada), 2000
BSc University of British Columbia (Canada), 1998

Contact


bhattip@gmail.com

Box 358080
WA

Research Interests

The bulk of my epidemiologic research has focused on genetic susceptibility to cancer following low dose exposure to occupational or medical ionizing radiation. More recently, I've developed an interest in epigenetic mechanisms, particularly DNA methylation, as markers of susceptibility to cancer and the modulation of these markers by various environmental exposures. In addition to ionizing radiation, exposures of interest include air pollution, persistent organic pollutants and shift work.

Recent Publications (PubMed)

The association of epigenetic age acceleration and multimorbidity at age 90 in the Women's Health Initiative.
(2022 Sep 15)
J Gerontol A Biol Sci Med Sci
Jain P, Binder A, Chen B, Parada H, Gallo LC, Alcaraz J, Horvath S, Bhatti P, Whitsel EA, Jordahl K, Baccarelli AA, Hou L, Stewart JD, Li Y, LaMonte MJ, Manson JE, LaCroix AZ

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
(2022 Sep 8)
Int J Cancer
Dicanio M, Giaccherini M, Clay-Gilmour A, Macauda A, Sainz J, Machiela MJ, Rybicka-Ramos M, Norman AD, Tyczyńska A, Chanock SJ, Barington T, Kumar SK, Bhatti P, Cozen W, Brown EE, Suska A, Haastrup EK, Orlowski RZ, Dudziński M, Garcia-Sanz R, Kruszewski M, Martinez-Lopez J, Beider K, Iskierka-Jazdzewska E, Pelosini M, Berndt SI, Raźny M, Jamroziak K, Rajkumar SV, Jurczyszyn A, Vangsted AJ, Collado PG, Vogel U, Hofmann JN, Petrini M, Butrym A, Slager SL, Ziv E, Subocz E, Giles GG, Andersen NF, Mazur G, Watek M, Lesueur F, Hildebrandt MAT, Zawirska D, Ebbesen LH, Marques H, Gemignani F, Dumontet C, Várkonyi J, Buda G, Nagler A, Druzd-Sitek A, Wu X, Kadar K, Camp NJ, Grzasko N, Waller RG, Vachon C, Canzian F, Campa D

Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma.
(2022 Aug 16)
J Hematol Oncol 15(1): 106
Chiu BC, Zhang Z, Derman BA, Karpus J, Luo L, Zhang S, Langerman SS, Sukhanova M, Bhatti P, Jakubowiak A, He C, Zhang W

Analysis of Epigenetic Age Acceleration and Healthy Longevity Among Older US Women.
(2022 Jul 1)
JAMA Netw Open 5(7): e2223285
Jain P, Binder AM, Chen B, Parada H Jr, Gallo LC, Alcaraz J, Horvath S, Bhatti P, Whitsel EA, Jordahl K, Baccarelli AA, Hou L, Stewart JD, Li Y, Justice JN, LaCroix AZ

Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
(2022 Sep 2)
Cancer Epidemiol Biomarkers Prev 31(9): 1863-1866
Macauda A, Clay-Gilmour A, Hielscher T, Hildebrandt MAT, Kruszewski M, Orlowski RZ, Kumar SK, Ziv E, Orciuolo E, Brown EE, Försti A, Waller RG, Machiela MJ, Chanock SJ, Camp NJ, Rymko M, Raźny M, Cozen W, Várkonyi J, Piredda C, Pelosini M, Belachew AA, Subocz E, Hemminki K, Rybicka-Ramos M, Giles GG, Milne RL, Hofmann JN, Zaucha JM, Vangsted AJ, Goldschmidt H, Rajkumar SV, Tomczak W, Sainz J, Butrym A, Watek M, Iskierka-Jazdzewska E, Buda G, Robinson DP, Jurczyszyn A, Dudziński M, Martinez-Lopez J, Sinnwell JP, Slager SL, Jamroziak K, Reis RMV, Weinhold N, Bhatti P, Carvajal-Carmona LG, Zawirska D, Norman AD, Mazur G, Berndt SI, Campa D, Vachon CM, Canzian F

Show complete publication list